NICE backing for Takeda's Adcetris for rare lymphoma
admin 10th July 2020 Uncategorised 0Standard of care in untreated systemic anaplastic large cell lymphoma (sALCL) has not changed in several decades
More: NICE backing for Takeda's Adcetris for rare lymphoma
Source: News